Please Wait...

DKK-1 // Dickkopf Related Protein-1

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Dickkopf family members are involved in the modulation of Wnt signaling. DKK1, the first member of this family (which comprises at least 4 cystein-rich protein), is an inhibitor of Wnt signaling. DKK1 has been found to not only promote bone resorption in a mouse model of arthritis but also to block bone formation and repair of diseased joint (Diarra et al., 2007). DKK1 appeared as a central player in bone homeostasis with implication in bone development and maintenance of bone mass as well as in formation of bone metastases (Pinzone et al., 2009).

Bioclinica Lab employs two manual immunoassays for the measurement of DKK1; one is dedicated to measurements in plasma EDTA and the second to measurements in serum.


Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

We're hiring recent tech grads in #RTP for #pharma sector! Our innov. clinical financial solution gives our client…
bioclinica (3 hours ago)
Great to be @DrugInfoAssn DIA China! Ask us @bioclinica how sponsors & CROs can optimize electronic data capture…
bioclinica (9 hours ago)
RT @bioclinica: Kinks in the clinical supply chain? Check out how one of our clients is using clinical supply optimization technology for m…
bioclinica (9 hours ago)
RT @bioclinica: Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (9 hours ago)
Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (Yesterday)
Case processing is an important aspect of post-marketing drug safety surveillance. Here's a case study showing how…
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen